Document Classification

Section Type: RESULTS

Text: At 12 weeks, comparing patients assigned to famotidine with patients assigned to placebo, gastric ulcers had developed in seven (3. 4 %) of 204 patients compared with 30 (15. 0 %) of 200 patients (odds ratio [OR] 0. 20, 95 % CI 0. 09-0. 47 ; p = 0. 0002) ; duodenal ulcers had developed in one (0. 5 %) patient compared with 17 (8. 5 % ; OR 0. 05, 0. 01-0. 40 ; p = 0. 0045) ; and erosive oesophagitis in nine (4. 4 %) compared with 38 (19. 0 % ; OR 0. 20, 0. 09-0. 42 ; p < 0. 0001), respectively.